NuvoAir

Digital health platform for respiratory care

Boston, Massachusetts, United States

About NuvoAir

NuvoAir focuses on enhancing respiratory care for patients with conditions like Asthma and Chronic Obstructive Pulmonary Disease (COPD). The company offers a digital health platform that combines home-delivered devices, real-time health data tracking, and virtual consultations with a dedicated care team. This approach allows patients and their healthcare providers to make informed decisions based on up-to-date health information. Unlike many competitors, NuvoAir provides a free trial for clinics, facilitating easier integration of its services into healthcare practices. The company operates on a subscription model, generating revenue through patient and provider subscriptions, and has shown significant results, including a 39.9% reduction in urgent consultations. NuvoAir aims to improve patient outcomes and accessibility to respiratory care across the U.S.

Boston, MassachusettsHeadquarters
2017Year Founded
$27.4MTotal Funding
SERIES_ACompany Stage
Consumer Software, HealthcareIndustries
51-200Employees

Benefits

Medical Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Flexible Work Hours
Paid Vacation
Paid Sick Leave
Annual Learning & Development stipend

Risks

Increased competition from companies like Aluna could impact market share.
Reliance on partnerships may pose risks if outcomes are not met.
Expansion into new markets requires significant investment and carries financial risks.

Differentiation

NuvoAir integrates advanced monitoring technology with evidence-based interventions for personalized care.
The company collaborates with health plans through value-based payment arrangements.
NuvoAir's platform offers real-time data tracking and virtual consultations for respiratory care.

Upsides

FDA clearance for Air Next Spirometer allows in-home use and continuous patient monitoring.
Partnership with Privia Medical Group enhances access to cardiopulmonary care in Georgia.
Recent $11M Series A funding supports expansion of digital healthcare solutions.

Funding

Total raised$27.43 M
Latest valuation$60.00 M
StageSERIES_A